What powers vidal.ru?
Last seen Jun 2026 · 8 technologies across 5 categories
Advertising
Analytics
JavaScript libraries
Miscellaneous
Web servers
Top search keywords
| Keyword | Position | Est. monthly visits |
|---|---|---|
| bivia | #99 | 320 |
| doxycycline hyclate | #85 | 320 |
| memantine | #93 | 230 |
| loperamide hydrochloride | #81 | 38 |
| meloxicam 7.5 | #91 | 38 |
| catarrhalis | #92 | 31 |
| b catarrhalis | #88 | 31 |
| moraxella branhamella | #95 | 31 |
| moraxella branhamella | #71 | 31 |
| neisseria catarrhalis | #95 | 31 |
| neurobion | #82 | 29 |
| clopidogrel 75 mg tablet | #85 | 25 |
| vidal | #88 | 21 |
| levofloxacin 500mg | #91 | 21 |
| levofloxacin 750 | #94 | 17 |
| chlorthalidone 25 mg | #96 | 16 |
| edarbi | #71 | 14 |
| omeprazole delayed release 40 mg | #82 | 13 |
| doxycycline hyclate vs doxycycline monohydrate | #84 | 11 |
| edarbyclor | #87 | 11 |
| magne | #91 | 9 |
| doxycycline monohydrate 100mg | #87 | 9 |
| streptococcus mitis | #99 | 8 |
| 4h2 | #75 | 8 |
| doxy mono vs hyclate | #94 | 8 |
The site's top keywords in Google (US), with the visits each one is estimated to bring per month.
Top backlinks
Top links pointing at the site, one per source domain, strongest first. The anchor text opens the page carrying the link.
Audience
- 92% phone
- 7% desktop
- 1% tablet
Russia
Kazakhstan
Uzbekistan
Moldova
Kyrgyzstan
Armenia
Countries where the site has Chrome traffic, strongest markets first.
Open Page Rank
5.65 / 10 · ranked #140,840 of all domains
461 referring domains · OpenPageRank
Search traffic
1,600 est. monthly organic visits (US)
1,021 keywords in Google's top 30
Core Web Vitals
| LCP | 1.5 s |
| INP | 75 ms |
| CLS | 0 |
| TTFB | 700 ms |
Real user p75, Chrome UX Report, Jun 2026.
Page
- Language: Russian
- Weight: 1.3 MB · 64 requests
- Structured data: JSON-LD, Microdata, OpenGraph
Homepage as crawled by the HTTP Archive, Jul 2026.
Full technology history →
Report an incorrect detection
Recent changes
- dropped Matomo Analytics Oct 2025
- detected Matomo Analytics Aug 2025